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Abstract
Large numbers of Mesenchymal stem/stromal cells (MSCs) are required for clinical relevant
doses to treat a number of diseases. To economically manufacture these MSCs, an auto-
mated bioreactor system will be required. Herein we describe the development of a scalable
closed-system, packed bed bioreactor suitable for large-scale MSCs expansion. The
packed bed was formed from fused polystyrene pellets that were air plasma treated to
endow them with a surface chemistry similar to traditional tissue culture plastic. The packed
bed was encased within a gas permeable shell to decouple the medium nutrient supply and
gas exchange. This enabled a significant reduction in medium flow rates, thus reducing
shear and even facilitating single pass medium exchange. The system was optimised in a
small-scale bioreactor format (160 cm2) with murine-derived green fluorescent protein-
expressing MSCs, and then scaled-up to a 2800 cm2 format. We demonstrated that placen-
tal derived MSCs could be isolated directly within the bioreactor and subsequently
expanded. Our results demonstrate that the closed system large-scale packed bed bioreac-
tor is an effective and scalable tool for large-scale isolation and expansion of MSCs.
Introduction
Mesenchymal stem/stromal cells (MSCs)-based therapies have potential utility in the treatment
of inflammatory diseases, the direct regeneration of mesenchymal tissues, or the up-regulation
of innate tissue repair processes [1]. The most widely studied and best characterized MSCs are
derived from bone marrow [2]. However, MSCs can be isolated from other tissues that may be
more accessible, including placenta, adipose tissue and umbilical cord [3–5]. Placental-derived
MSCs (pMSCs) are an attractive source of MSCs, as they not only behave similarly to bone
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marrow derived MSCs [5], but a single placenta (500–700 g tissue) is sufficient for manufactur-
ing several hundred units of allogeneic MSCs [6].
Regardless of the tissue source, MSC populations will require in vitro expansion to generate
clinically relevant cell numbers. Many promising therapies require single or multiple doses of
approximately 2 x 106 cells/kg [7]. For MSC-based therapies to become a routine and economi-
cally viable treatment approach, the most efficient and cost effective method for their large-
scale manufacture will require an automated closed-system bioreactor.
Bioreactor designs used for MSC expansion include micro-carrier suspensions in spinner
flasks, stirred tank reactors, and perfusion reactors, such as fixed beds or hollow fibre bioreac-
tors [6,8–10]. Simple micro-carrier suspension cultures achieve a large surface area for adher-
ent cell culture. However, there is no connectivity between individual micro-carriers, and
empty micro-carriers do not contribute to the total surface area available to the culture. As a
result, some micro-carriers rapidly reach confluence, whilst others remain empty; this requires
frequent passaging to overcome localized space limitations [6,11]. Micro-carrier cultures also
require mixing to enable nutrient exchange and prevent concentration gradients. The shear
forces arising from mixing must be carefully modulated, as this can compromise MSC stem-
ness characteristics during expansion [12,13]. Packed bed bioreactors potentially solve both
problems by providing a continuous and connected surface area with no need for mixing.
However, the maximum perfusion flow velocity cannot exceed 3 x 10−4 m/s without
compromising the growth rate [14]. This greatly limits the scalability, as both soluble nutrients
and oxygen must be supplied by medium perfusion alone.
The bioreactor design described here overcomes these problems by incorporating a gas per-
meable polydimethylsiloxane (PDMS) shell, which decouples the bulk medium perfusion from
the supply of oxygen. This allows a reduced perfusion flow rate or even a single pass medium
supply. Fused polystyrene pellets are used to construct a scaffold, that is subsequently air
plasma treated to generate charged functional groups on the surface, which promotes cell
attachment similar to commercial tissue culture polystyrene (TCP) [15]. Bubble formation
within the bioreactor caused by pressure drops and temperature changes across the bioreactor
was prevented by pressurizing the waste reservoir to 2 PSI. The system was initially optimised
using an immortalized murine MSC population, and then the system was demonstrated to
be suitable for the direct isolation of pMSCs from placental tissue digest and subsequent
expansion.
Materials and Methods
Single Pass Small-Scale Bioreactor Design
This system contained a 1.5 cm diameter by 7.5 cm long scaffold providing a total surface area
of 160 cm2, connected to a single pass circuit (Fig 1A). A 5 mm thick polydimethylsiloxane
(PDMS, Dow Corning, MI, USA) tube was moulded to just fit the polystyrene scaffold with an
additional 1 cm head space to function as a bubble trap. Perfused medium was driven by a
syringe pump (New Era Pump Systems Inc., NE-1800, Farmingdale, NY, USA) that was main-
tained outside the incubator. Medium was firstly perfused through a 30 cm length of 16 mm
diameter silastic tubing (Cole-Parmer, IL, USA) to enable conditioning of the medium before it
entered the bioreactor flow cell. The rest of the tubing set was constructed of 1.6 mmMaster-
flex PharMed BPT tubing (Cole-Parmer, IL, USA).
Recirculating Large-Scale Bioreactor Design
A recirculating system was implemented as shown in the process flow diagram (Fig 1C). The
large-scale bioreactor is a 5 cm diameter by 12 cm scaffold, providing a total surface area of
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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Fig 1. Description of packed bed bioreactor and results from the steady state oxygenmass balance. (A) Process flow diagrams of the single pass
small-scale 160cm2 bioreactor and (C) recirculating perfusion for the large-scale 2800cm2 bioreactor. (B) Picture of 160 cm2 left and 2800 cm2 right
bioreactor scaffolds made from 3 mm polystyrene pellets (scale bar is 10 mm). (D) 2800 cm2 bioreactor inside the incubator. (E) Mass transport model result
for radial oxygen diffusion with cell density of 100,000 cells/cm2 in small-scale (160 cm2) and (F) large-scale (2800 cm2) packed bed bioreactors.
doi:10.1371/journal.pone.0144941.g001
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2800 cm2, encased in a 5 mm thick PDMS tube. The peristaltic pump (Watson Marlow Alitea,
403V/VM 4, Stockholm, Sweden) was located outside the incubator. A single 3 mm diameter
Masterflex PharMed BPT tubing passed through the peristaltic pump and was expanded into
two 30 cm lengths of 1.6 mm diameter silastic tubing to allow conditioning of the medium for
the inlet. This was then further expanded into the four 1.6 mm inlet holes into the bioreactor.
Medium then left the bioreactor via the four 1.6 mm outlet holes, reducing firstly into two 30
cm lengths of 1.6 mm diameter silastic tubing and finally one 3 mm diameter Masterflex
PharMed BPT tubing into the reservoir (Fig 1E).
Large Surface Area Polystyrene Scaffold
Scaffolds are constructed from 3 mm diameter by 2.5 mm length fused polystyrene cylindrical
pellets (a generous gift from Paul Reynolds of Styron, PA, USA). The pellets were fused
together by passing Acetone through a mould with a 1.5cm diameter for the small-scale and a
5 cm diameter for the large-scale. The surface area of the scaffold was calculated by using the
mass of the column and the volume estimate was confirmed by measuring the void volume.
Details of the plasma reactor used to treat the polystyrene scaffolds have been reported pre-
viously [16]. In brief, the plasma reactor was loaded with the untreated scaffold columns, sealed
and pumped under vacuum to a base pressure of 7x10-3 mbar. Air was then introduced into
the reactor at a flow rate of 4 cm3/min, while the chamber was rotating at approximately 10 rev-
olutions per minute. Plasma was ignited at 50 W for a total period of 10 minutes.
Prevention of Bubble Formation in Bioreactor Systems
To prevent bubble formation due to pressure drop and temperature changes in the system, the
system was pressurised with air at 2 PSI (13.79 kPa) using a low pressure two stage gas regula-
tor (Gascon Systems, Thornbury, Vic, Australia) and a pressure safety valve set at 2 PSI (Gen-
erant, Butler, NJ, USA).
Air Plasma Treated Polystyrene Scaffold Characterisation
Surface analysis was carried out using Axis Ultra DLD spectrometer (Kratos, Manchester UK.)
using a monochromatic Al Kα X-ray source operating at 225 W, which corresponds to an
energy of 1486.6 eV. The area of analysis was 0.3 x 0.7 mm and an internal flood gun was
employed to minimize the charging of the samples. The survey spectra were collected at a dwell
time of 55 ms with 160 eV pass energy at steps of 0.5 eV with three sweeps. The collected data
was then analysed and processed using CasaXPS (ver.2.3.16 Casa Software Ltd. 1) utilizing
Shirley baseline correction. To compensate for the charging effects, the C-C peak was offset to
284.8 eV in all spectra. Finally, all atomic percentages were mathematically rounded to one
digit after the comma.
pMSC Isolation and Cell Culture
Placenta was obtained from full term elective Caesarean sections with written patients’ consent
and ethics approval from Queensland University of Technology Human Ethics Committee
(1000000938). The method used to isolate pMSCs from the placenta has previously been
reported in [6,17], it results in a product of<1% CD45+ and>90% CD73+/CD105+. Briefly,
10 g of placental tissue cut into 5 mm pieces were digested in a 50 mL falcon tube with DMEM
low glucose (Invitrogen), 100 Units/mL C ollagenase I (Worthington) and 2.5 μg/mL DNase I
(Roche) that was incubated at 37°C for 2 hours on a shaker (250 RPM). The cell supernatant
was passed through a 70 μm cell strainer (BD Falcon) and was centifuged at 400g for 5 minutes.
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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The supernatant was removed and the cell pellet resuspended in PBS and mononuclear cells
were then isolated using a Ficoll-Paque (GE Healthcare) density gradient at 400 g for 30 min-
utes. The mononuclear layer was collected and washed with PBS and finally the cells were
resuspended in low glucose DMEM supplemented with 10% fetal bovine serum (Thermo-
fisher) and 100 units/mL penicillin, and 100 μg/mL streptomycin (Life Technologies) (referred
to DMEM 10% FBS from here on) and seeded into a single T175 flask. The cells were then
incubated in 20% oxygen, 5% CO2 at 37°C for 24 hours to allow adherent cells to attach. The
flask was washed and fresh medium was added. The flask was placed into a hypoxic incubator
(2% oxygen and 5% CO2). This process was standardised in our group for MSC isolation
procedures [18]. The medium was replaced twice a week until the monolayer was 80–90% con-
fluent before passaging. The pMSCs were harvested and cryogenically stored after passage one.
Primary green fluorescence protein labelled mouse mesenchymal stromal cells (GFP-
mMSCs, generous gift fromMater Medical Research Institute) were isolated from the bone
marrow of UBI-GFP/BL6 mice in accordance with The University of Queensland Animal Eth-
ics Committee, previously published and described in [19,20]. The GFP-mMSCs were main-
tained in DMEM 10% FBS and incubated in standard cell culture conditions (37°C and 5%
CO2).
Comparison of Air Plasma Treated Polystyrene and Commercial Tissue
Culture Plastic on Cell Growth Rate and Attachment
Non-tissue culture treated polystyrene 60 mm Petri dishes (Sigma-Aldrich) were plasma
treated in the same manner as the polystyrene scaffolds above. To assess cell attachment, the
air plasma treated Petri dishes and T75 flasks (Nunc) were seeded at 2000 cells/cm2 with GFP-
mMSCs in DMEM 10% FBS. The cells were permitted to attach for one and a half hours. The
adhered cells were detached and then counted on an FC 500 flow cytometer (Beckman and
Coulter, USA) using flow cytometry counting beads (Beckman and Coulter, USA). To compare
the growth rate, plasma treated Petri dishes and T75 flasks were seeded with GFP-MSCs at a
density of 1000 cells/cm2 and incubated for 3 days in DMEM 10% FBS. The cells were then har-
vested and counted via flow cytometry as described above.
Expansion of GFP-mMSCs in the Packed Bed Bioreactor
The 160 cm2 bioreactor was seeded at 1000 cells/cm2 of GFP-mMSCs suspended in DMEM
10% FBS. To distribute the cells evenly, the bioreactor was placed on a tube rocker roller set at
5 RPM for 10 minutes, followed by 5 minutes of rest in an incubator and repeated for 3 hr. As a
2D control, GFP-mMSCs were seeded at a density of 1000 cells/cm2 in T175 flasks (Nunc). The
GFP-mMSCs were grown either under static conditions or perfusion (5 mL/day) in the biore-
actor. The cell number was quantified every two days by replacing the medium with a 1:50 dilu-
tion of AlamarBlue in DMEM 10% FBS medium and incubated for three hours. The reacted
AlamarBlue medium was replaced with fresh DMEM 10% FBS and the culture was continued.
The fluorescence signal of the AlamarBlue in medium was measured in a plate reader (FLUOs-
tar Omega, BMG Labtech, Germany) along with a cell titration to infer cell numbers using exci-
tation and emission filters of 544 and 590.
Packed Bed Bioreactor Harvest and Harvest Efficiency
The bioreactor was washed with one reactor volume of PBS and replaced with one reactor vol-
ume of 0.01% Trypsin EDTA (Gibco). The Bioreactor was then incubated (5% CO2 and 37°C)
for 15 minutes. The detached cells were removed by first draining the Trypsin solution and
then pumping through three reactor volumes of DMEM 10% FBS. Live cells numbers were
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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determined by an automated cell counter (Bio-Rad TC20, CA, USA) using Trypan Blue. This
number was compared to the Alamar Blue result to estimate the percentage of live cells
removed from the bioreactor.
Packed Bed Bioreactor Imaging
For direct imaging of the GFP-mMSCs attached to the 160 cm2 column at the end of culture,
the column was removed and fluorescence microscopy (Nikon Eclipse Ti-u with a Nikon Digi-
tal Sight Ds-Qimc camera, Japan) was used to image GFP expressing cells.
To image the whole bioreactor using the IVIS Imaging System 200 series (Caliper, PerkinEl-
mer, MA, USA), the cells were fixed with 4% paraformaldehyde and were stained with 10 μg/
mL propidium iodide (PI, Invitrogen) for 10 minutes. The bioreactor was then washed with
PBS and stored on ice prior to imaging. As negative controls, bioreactors containing no cells
underwent the same fixing and staining process. The bioreactors were imaged with an excita-
tion filter of 520 nm and an emission filter of 620 nm. The thresholds were adjusted to remove
background auto florescence.
Pre-Isolated pMSCs Expansion in the Packed Bed Bioreactor
The 160 cm2 scaffold bioreactor was seeded through the injection port with 1000 cells/cm2 of
passage four pMSCs suspended in DMEM 10% FBS, using the same seeding process, culture
conditions and 2D controls as the expansion of the GFP-mMSCs. However, in the perfusion
experiment the cell numbers were quantified by AlamarBlue at the end of the culture. The cells
were then harvested and characterised by mesodermal tri-lineage differentiation capacity.
pMSCs Isolation and Expansion in the Packed Bed Bioreactor
The placental tissue was digested by the same method outlined in the pMSC isolation and cell
culture section above. Instead of a density gradient the filtered cell suspension from the 10 g of
starting tissue was seeded into the bioreactor or into a T175 flask, using the same seeding
method outlined in the GFP-mMSC expansion. After 24 hours, the cell suspension was
removed, the medium was replaced and the flow rate was adjusted in the bioreactor to 5 mL/
day. Once the pMSC colonies were observed in the T175 flasks, the cells were harvested in both
the bioreactors and flasks and reseeded into the same bioreactor or flask to continue the expan-
sion process. The cell number was monitored using the AlamarBlue. The cells where harvested
once reaching confluence and characterised by mesodermal tri-lineage differentiation capacity.
Scale-up of GFP-mMSC in Bioreactor
The 2800 cm2 bioreactor was seeded at 1000 cells/cm2 with GFP-mMSCs suspended in DMEM
10% FBS using the injection port. The T175 flasks function as a 2D control. The same seeding
procedure as per the small-scale expansion experiments was followed. The reservoir was filled
with 250 mL of DMEM 10% FBS to give a total medium volume of 360 mL in the circuit (biore-
actor volume 110 mL). The medium was pumped in the recirculating circuit at 0.5 mL/min. A
1 mL medium sample was taken from the injection port each day. In addition, at the end of the
culture period an additional 1mL sample was taken from the bulk medium in the reservoir.
Glucose and lactate concentrations were quantified by the Mater Hospital Pathology labora-
tory. At the end of expansion, the cell numbers were quantified by the AlamarBlue method.
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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Mesodermal Differentiation
Osteogenic differentiation was achieved by culturing pMSCs in induction medium containing
high glucose DMEM (HG DMEM, Invitrogen) supplemented with 10% FBS, 10 mM β-glycerol
phosphate (Sigma-Aldrich), 100 nM Dexamethasone (Sigma-Aldrich) and 50 μM L-ascorbic
acid 2-phosphate (Sigma-Aldrich). The calcium deposits were visualised by staining with Ali-
zarinRed S (Sigma-Aldrich). Alkaline phosphatase (ALP) activity was quantified with p-nitro-
phenyl Phosphate (Sigma-Aldrich) following manufacturers’ instructions, measuring the
absorbance at 405 nm after a 30 minute incubation.
Chondrogenesis was induced using cultures of 200,000 cell pellets grown in HG DMEM
supplemented with 110 μg/mL sodium pyruvate (Invitrogen), 10 ng/mL recombinant human
Transforming Growth Factor β1 (TGF-β1, Peprotech), 100 nM dexamethasone, 200 μM ascor-
bic acid 2-phosphate, 40 μg/mL L-proline (Sigma-Aldrich) and 1% ITS-X (Invitrogen). 75% of
the chondrogenic medium was changed every two days, the collected medium was stored at
-20°C for subsequent glycosaminglycan (GAG) analysis. GAG was visualized by staining frozen
sections of the cell pellets with Alcian Blue (Sigma-Aldrich). GAG was then quantified by first
digesting the pellets in papain and then staining with 1,9-Dimethyl-methylene blue zinc chlo-
ride double salt (Sigma-Alrich).
Adipogenic differentiation was induced over 2 weeks with HG DMEM supplemented with
10% FBS, 10 μM insulin (Invitrogen), 1 μM dexamethasone, 200 μM indomethacin (Sigma-
Aldrich) and 500 μM 3-isobutyl-1-methyl-xanthine (Sigma-Aldrich). Lipid droplets were visu-
alised by staining with Oil Red O (Sigma-Alrich) and were quantified with an adipogenensis
detection kit (Abcam) following the manufacturer’s protocol.
The DNA was quantified by PicoGreen dsDNA Reagent Kit (Invitrogen) following the
manufacturer’s protocol.
Steady-state Oxygen Mass balance
Amass balance calculation crudely estimates the concentration of oxygen at any point along
the radius by a simple source sink method. A more sophisticated theoretical treatment was
applied, but will be published elsewhere. It was assumed that there was no axial flow and that
oxygen only diffused radially; no axial diffusion was considered. Eq 1 describes the concentra-
tion of oxygen in the bioreactor vessel, while Eq 2 describes the oxygen concentration in the
wall of the bioreactor. CR1 (mM) is the concentration at the inner bioreactor radius (R1,cm)
which is the solubility of oxygen in the medium (0.2 mM), CR2 is the concentration at the outer
bioreactor R2 radius which is the solubility of oxygen in PDMS (1.3 mM) [21], Cr is the concen-
tration at any point of the radius r, K is the specific volumetric uptake of oxygen (mM/cm3/s),
derived from bioreactor dimensions and MSCs oxygen uptake rate of 2.5x10-17 mM/s/cell [22],
DR is the corrected diffusion coefficient of oxygen within the bioreactor vessel and Dpdms is the
diffusion coefficient of PDMS (5.0x10-5 cm2/s [21]).
Cr ¼ CR1 
K
4DR
R2  r2ð Þ  KR1
2
2Dpdms
ln
R2
R1
 
0  r  R1 ð1Þ
Cr ¼ CR2 
KR1
2
2Dpdms
ln
R2
r
 
R1  r  R2 ð2Þ
However, as the bioreactor vessel space is ﬁlled with non-gas permeable particles, a correc-
tion factor (Eq 3) was applied to the diffusion coefﬁcient based on the voidage (ε), sphericity
(φ, Eq 5) and tortuosity (τ, Eq 4). The voidage, calculated as the difference between the empty
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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volume of the bioreactor and the liquid volume injected into the bioreactor, was found to be
0.4.
DR ¼
ε
t
Dm ð3Þ
Correction factor for oxygen diffusion coefﬁcient in medium Dm (3.290x10-05 cm2/s [23]),
is a function of voidage (ε) and tortuosity (τ).
t ¼ 1:23ð1 εÞ
4
3
ε φ2 ð4Þ
Tortuosity is a function of the voidage and sphericity (φ). Equation taken from [24].
φ ¼ ð36 p nð1 εÞ
2Þ13
a
ð5Þ
Sphericity is calculated based on the number of particles (n), the voidage (ε) and the surface
area to volume ratio (a). Equation taken from [24].
To calculate the shear stress from the medium perfusion, the pressure drop (ΔP) was first
calculated by the Ergun equation:
DP ¼ 150mð1 Þ
2VSL
ε3D2p
þ 1:75ð1 εÞrV
2
s L
3Dp
ð6Þ
The viscosity (μ) of the medium is 0.008 poise [25], the density of the medium (ρ) is 0.99 g/
cm3[26], Vs is the superficial velocity, Dp is the diameter of the particles and L is the length/
height of the packed bed. To calculate the shear force (τ) the pressure drop was multiplied by
the cross sectional area of the fluid flow (pD
2ε
4
) and divided by the surface area of the ﬂuid con-
tacting the scaffold (growth area of the scaffold, i.e. 160 cm2 and 2800 cm2).
Statistics
Results are expressed as means and standard deviations of four biological replicates. Differ-
ences were determined by T-test using SPSS statistics (ver 17, SPSS Inc, Chicago) and values of
p0.01 were considered significant.
Results
Steady-state Oxygen Mass balance
The bioreactor mass transport model was used to estimate the steady-state oxygen concentra-
tion along the radius at a cell concentration five times the maximum confluence of MSCs
(100,000 cells/cm2). The mass balance predicted no significant oxygen gradient in the small-
scale 160 cm2 bioreactor (Fig 1E). However, in the larger 2800 cm2 bioreactor, a drop in oxygen
concentration of 0.2 mM to 0.146 mM in the centre was predicted (Fig 1F). As the PDMS wall
offered negligible resistance to oxygen diffusion in both configurations, the only factor limiting
the oxygen concentration in the bioreactor was the oxygen solubility in the medium.
The Ergun equation was used to calculate the shear due to fluid flow in the bioreactor. The
hydrodynamic shear from the medium perfusion in the small bioreactor (5 mL/day) and large
bioreactor (0.5 mL/min) was calculated to be 9.5x10-5 Pa and 1.25x10-3 Pa, respectively.
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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Plasma Treated Polystyrene Scaffold Characterisation
The rotary air plasma treatment greatly increased the charged oxygen groups on the surface on
the polystyrene (Fig 2A), providing a similar growth surface chemical composition to commer-
cial TCP [15]. However, high amounts of silicon and oxygen contamination in the untreated
polystyrene was detected. This was likely because the PDMS mould used to make the scaffold
is known to leach unreacted polymer which contains silicon and oxygen [27].
The attachment and growth of GFP-mMSC were compared on our plasma treated surface
in 2D and commercial TCP. Only half of the 3000 cells/cm2 seeded attached to the plasma
treated surface after one and half hours (Fig 2B). However after 3 days the cell number on the
plasma treated surface was equivalent to commercial TCP (Fig 2C). Following this observation,
the seeding period for the bioreactor experiments was extended to 3 hours to allow more robust
cell attachment.
GFP-mMSCs Expansion in Small-scale Packed Bed Bioreactor
The GFP-mMSCs growth rate in the bioreactor was significantly less than the 2D controls
under both static and perfusion conditions (Fig 2D & 2E) with the doubling time of 30.19±0.6
hr and 26.48±0.49 hr, respectively for static conditions and 27.18±0.8 hr and 24.59±0.53 hr,
respectively under perfusion conditions (5 mL/day). The cells were harvest from the bioreactor
with an efficiency of 84%±11% with a cell viability of 71%±15% (Fig 2F).
The cells formed a monolayer on the fused pellets and maintained a spindle-like morphol-
ogy. In addition, the cells were observed to grow across the connection between the beads (Fig
2G, 2H, 2I & 2J). IVIS imaging used the fluorescent intensity of the PI stained cells to estimate
the global distribution of cells within the bioreactor. Under both static and perfusion condi-
tions, fluorescence intensity was homogeneous within the scaffold (Fig 2K & 2L), suggesting
that the cells could be homogeneously distributed in the scaffold.
Human Placental MSCs Expansion in Small-Scale Packed Bed
Bioreactor
Passage 4 human pMSCs were expanded under static conditions and perfusion conditions. The
doubling time of bioreactor expanded cells took longer than the 2D controls (T175 flask),
63.5±1.5 hr and 43.7±1.5 hr, respectively for static (Fig 3A) and 49.2 ± 2.6 hr and 37.9 ± 0.9 hr,
respectively for perfusion (Fig 3B). A single end point quantification protocol after seven days
of expansion was adopted in the perfusion experiments, due to the disruption caused to the
cells by taking a measurement every two days. This resulted in a reduced difference in the dou-
bling times between perfused bioreactor grown cells and the 2D controls. IVIS images of
pMSCs expanded under perfusion conditions displayed an even fluorescent intensity from the
scaffold; a suggestion of homogeneous distribution of cells (Fig 3C). Note that due to the resid-
ual medium trapped in the syringe port resulted in a high intensity fluorescent signal detected
by the IVIS.
The cells were characterised by mesodermal tri-lineage differentiation There was no differ-
ence between the bioreactor expanded cells in both static and perfusion conditions and the cor-
responding 2D controls when stained with Oil Red O, AlizarinRed S or Alcian Blue (Fig 3D).
This was confirmed with no difference in the triglycerides amount and ALP activity (Fig 3E &
3F). However, there was significantly less GAG production in the cells expanded in the bioreac-
tor under static conditions relative to the 2D control (Fig 3G).
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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Isolation and Expansion of Placental MSC Directly in Small-Scale
Packed Bed Bioreactor
pMSCs were isolated from 10 g of digested placenta directly into the bioreactor was expanded
under 5 mL/day perfusion. The growth rate of pMSCs was slower in the bioreactor compared
to the 2D controls (Fig 4A). The pMSC colonies were becoming confluent following 13 days of
culture in the 2D controls, at this point the cells were re-seeded back into the same flask or bio-
reactor, and the expansion was continued. At day 18 the 2D controls reached confluence and
were harvested and characterised by mesodermal tri-lineage differentiation. The bioreactor
pMSCs’ cultures were harvested at day 22.
The qualitative differential potential of the osteogenic, chondrogenic and adipogenic line-
ages were similar as shown by staining between the bioreactor expanded pMSCs and the 2D
controls (Fig 4B). However, when quantified (Fig 4C, 4D & 4E) there was a significant differ-
ence in ALP activity between bioreactor isolated and expanded cells compared to the 2D
controls.
Scale-up of the Packed Bed Bioreactor
GFP-mMSC was used to demonstrate the scale up potential of a larger 250 mL vessel that pro-
vided 2800 cm2 of growth surface. The cell growth was significantly slower in the bioreactor
than in the 2D controls, with doubling times of 21.5 ± 0.1 hr and 20.8 ± 0.4 hr, respectively (Fig
5A). The medium perfusion rate was increased to 0.5 mL/min from the small-scale experi-
ments to provide adequate glucose to the cells. The glucose levels were nearly depleted in the
bioreactor and the reservoir by day 5 (Fig 5B), suggesting either that the medium must be
changed every three to four days or that a larger medium reservoir is required.
The IVIS imaging showed heterogeneous fluorescence intensity, implying that the seeding
method is not as robust when scaled-up to the large-scale bioreactor compared to the small-
scale bioreactor (Fig 5C, 5D, 5E & 5F).
Discussion
The packed or fixed bed bioreactors, like many other bioreactor designs, rely either on the per-
fusion or mixing of the medium to provide the two limiting metabolites, glucose and oxygen.
Due to the low oxygen solubility, the perfusion or mixing rates must be high to meet the oxy-
gen demand from the expanding cells and to prevent depletion and significant gradients
[14,28]. Such high perfusion rates can potentially cause shear stress on the cells, which has
been shown to reduce cell growth rate and induce differentiation. A shear force of 0.015 Pa has
been reported to up-regulate osteogenic pathways in human bmMSCs [12–14,29]. Our biore-
actor employed a gas permeable wall to decouple the oxygen supply from the bulk medium
perfusion, resulting in lower flow rates and putatively decreasing the shear force to which the
cells are exposed to an estimated 9.5x10-5 Pa for the small-scale bioreactor and 1.25x10-3 Pa for
the large-scale bioreactor. In addition, the lower medium volume required for tissue culture
would represent a significant cost saving.
Fig 2. Characterisation of plasmamodified surface and GFP-mMSCs expansion in our packed bed bioreactor in static and perfusion conditions.
(A) Surface composition of the air plasma treated polystyrene scaffold determined by XPS. (B) GFP-mMSC attachment after one and half hours, initially
seeded at 3000 cells/cm2 (n = 4). (C) The growth after 3 days of culture of GFP-mMSC seeded at 1000 cells/cm2 (n = 6). (D) Growth of GFP-mMSC in the
bioreactor (BR) under static conditions (n = 4) and (E) under 5 mL/day perfusion (n = 4). (F) Cell harvest recovery and viablity from the bioreactor. (G, H, I and
J) Fluorescent microscopy showed that the GFP-mMSC attached to the scaffold (scale bar is 500 μm). (K) IVIS imaging of the fluorescent intensity of PI
stained GFP-mMSC in the bioreactor under static and (L) 5 mL/day perfusion conditions. IVIS images are a red (low) / yellow (high) heat map of fluorescent
intensity.
doi:10.1371/journal.pone.0144941.g002
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Fig 3. Pre-isolated passage four pMSC expanded in our bioreactor in static and perfusion conditions. (A) pMSC expansion in the small-scale 160 cm2
bioreactor (BR) in static (n = 4) and (B) 5 mL/day perfusion (n = 4), with the 2D controls (2D). (C) IVIS imaging of PI stained pMSC under perfusion conditions.
IVIS images are a red (low) / yellow (high) heat map of fluorescent intensity. (D) Two week tri-lineage mesodermal differentiation induction of bioreactor
MSCs Isolation and Expansion in a Packed Bed Bioreactor
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The overall growth rate of pMSCs expanded in the bioreactor was less than that observed
for traditional flask expanded cells (Figs 2E & 3B), and was similar to bmMSCs and pMSCs
expansion growth rates reported for other bioreactor designs [6,8,30,31]. Medium perfusion
enhanced the growth rate of both GFP-mMSC and pMSC, consistent with literature observa-
tions [6,8,30,31].
This impaired bioreactor growth rate relative to traditional tissue culture flasks could be
attributed to surface chemistry and geometry of the scaffold or to the method used to seed the
bioreactor. However, our air plasma treated polystyrene surface provided a comparable surface
to commercial grade tissue culture plastic (Fig 2A), and the growth rate was comparable to
commercial TCP (Fig 3C). Thus, the impaired growth rate observed in the bioreactor cannot
expanded pMSC and 2D controls down the adipogenic (Oil Red O, 10x, scale bar is 100 μm), osteogenic (Alizarin Red, 5x, scale bar 500 μm) and
chondrogenic (Alcian Blue, 10x, scale bar 500 μm) lineages. Quantification of (E) triglycerides (n = 4), (F) ALP activity (n = 4) and (G) GAG production.
doi:10.1371/journal.pone.0144941.g003
Fig 4. Isolation of pMSCs from digested placental tissue in our packed bed bioreactor. (A) cell growth of pMSCs isolated directly from a placenta in the
160 cm2 packed bed bioreactor undergoing 5 mL/day perfusion (n = 4). On day 13, the cells were redistributed back into the same flask or bioreactor.
# indicating no 2D control result was measured as the flask was harvested on day 18. (B) Two week mesodermal tri-lineage differentiation induction of
bioreactor expanded pMSC and 2D controls down the adipogenic (Oil Red O, 10x, scale bar is 100 μm), osteogenic (Alizarin Red, 5x, scale bar 500 μm) and
chondrogenic (Alcian Blue, 10x, scale bar 500 μm) lineages. Quantification of triglycerides (n = 4) (C) and ALP activity (n = 4) (D) GAG (E) production
compared to its matching 2D control (n = 4).
doi:10.1371/journal.pone.0144941.g004
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be entirely attributed to chemical differences in surface composition. The inefficiencies in the
cell seeding process can also strongly affect the growth rate. A noticeable uneven cell distribu-
tion was observed in the scaled-up bioreactor (Fig 5C, 5D, 5E & 5F). The geometric features of
the bioreactor scaffold surface alter the contact inhibition characteristics of cell colonies, which
would be likely to reduce the observed growth rate. In addition, the collision rate during seed-
ing, defined as the rate at which cells contact the scaffold, would be greatly reduced on these
3D structures in dilute cell suspension [11]. Of the many bioreactor seeding methods reported
in the literature, no method was completely efficient [14,32–34].
Despite the significant decrease in growth rate in our bioreactor, the pMSCs maintained the
capacity to differentiate down the osteogenic, adipogenic and chodrogenic lineages. No differ-
ences in mesodermal tri-lineage differentiation were observed under the perfusion expansion
protocol (Fig 3E, 3F & 3G). However, the GAG production in static bioreactor-expanded cells
diminished relative to 2D controls. As preconditioning MSCs to a higher oxygen concentration
reduces their capacity to differentiate down the condrogenic linage, reduced GAG production
could be explained by a higher oxygen concentration present in the bioreactor compared to the
traditional tissue culture flask, [35,36]. The liquid layer in a traditional tissue culture flask offers
greater resistance to oxygen diffusion resulting in a lower concentration of oxygen at the cell
Fig 5. GFP-mMSC expansion in a scaled-up packed bed bioreactor (A) The fold expansion of GFP-mMSC in a scaled-up bioreactor under 0.5 ml/
min perfusion with T175 flask control (n = 4). (B) Glucose and lactate levels in the bioreactor (n = 3). (C, D, E & F) IVIS imaging of the fluorescent
intensity of PI stained GFP-mMSC in the bioreactor. IVIS images are a red (low) / yellow (high) heat map of fluorescent intensity.
doi:10.1371/journal.pone.0144941.g005
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layer [37]. MSCs in the bioreactor located at the liquid-wall interface are exposed to far higher
oxygen concentration.
To further characterise the bioreactor’s effect on MSCs stemness, and to demonstrate the
flexibility of the design, pMSCs were isolated from a digested placenta directly into the bioreac-
tor. The pMSCs produced from this protocol maintained their potential to differentiate down
the adipogenic, osteogenic and chondrogenic lineages (Fig 4B). However, the bioreactor-
expanded cells exhibited greater ALP activity than the analogous traditional tissue culture flask
expanded pMSCs (Fig 4D). During isolation, large amounts of red blood cells and other dead
cell debris could not be removed and remained within the bioreactor column. As dead cells
have been reported to contribute to, and possibly even induce, osteogenesis in bmMSCs [38],
such debris could pre-condition bioreactor-isolated pMSCs toward osteogenic differentiation.
The manual syringe driven process used in this experiment made removing the cell debris
from the bioreactor difficult. A steady flow rate was difficult to achieve using this manual
method, so the flow rate was kept low to avoid detaching the cells from the scaffold. Automated
medium flow in future generations of the bioreactor will help prevent this build-up of cell
debris, as a controlled continuous flow will allow higher flow rates without detaching the cells
from the scaffold. An increased flow rate used in the expansion process in the scaled-up biore-
actor will also actively remove cell debris.
Although the growth rate of pMSCs in the bioreactor was less than the cells grown on tissue
culture plastic, the few extra days required for MSCs to reach confluence in the packed bed bio-
reactor represents an acceptable trade-off to have the potential for an automatable method to
digest, isolate and expand pMSCs in a single closed bioreactor system. An isolation/expansion
process based on our design, although performed manually here, could be easily automated
[6]. Thus, a single automated bioreactor imbedded with an automated isolation protocol might
be developed to digest, isolate and expand pMSCs for clinical use with single procedure in a
completely closed system. Additionally, the theoretical scaffold height in our bioreactor design
is now defined by the much higher glucose concentration, therefore the potential radius of our
bioreactor is only limited by the radial diffusion of oxygen [8,14]. The radius limitation might
be overcome by embedding coils within the packed bed scaffold, similar to those found in iso-
thermal chemical reactors, constructed of gas permeable PDMS or silicon to optimise oxygen
mass transfer. Although our scale-up described here focused only on increasing the actual reac-
tor size, decreasing the pellet size to 0.5 mm and the total surface area to 1.8 m2 would be far
more efficient in increasing the reactor capacity. This potentially could support 2 x 108 cells
using the same dimensions as our larger bioreactor (5 cm diameter and 12 cm height).
Conclusion
The packed bed bioreactor designed to decouple the oxygen transport from the bulk nutrient
supply from the medium flow operates efficiently at a lower perfusion rate, resulting in lower
shear stress acting on the cells. We observed a 10 fold expansion of pMSCs in the bioreactor
after a one week culture, while still maintaining their differential potential. In addition, pMSC
isolated and expanded directly onto the bioreactor still maintained their mesodermal tri-line-
age differentiation potential. This design is scalable and potentially automatable. Although the
growth rate of pMSCs in the bioreactor was less than the cells grown on tissue culture plastic,
the few extra days required for MSCs to reach confluence in the packed bed bioreactor repre-
sents an acceptable trade-off to have the potential for an automatable method to digest, isolate
and expand pMSCs in a single closed bioreactor system.
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